Pan-government working group for COVID-19 was established

A public-private joint government presided over by the President

Pan-government working group for the development of treatments and vaccines for COVID-19, a public-private joint government presided over by the President, was established.

 

In the future, the Working Group plans to serve not only for R&D, but also for full-time support such as production, national stockpiling, and the use of a quarantine site.

 

On the 17th, the government announced that it had formed a joint public-private joint government support group to provide rapid results by intensively supporting the development of COVID-19 treatments and vaccines through a joint meeting of industry, academia, research, and hospitals presided over by the president on the 9th.

 

The support group is co-directed by the Minister of Health and Welfare and the Minister of Science, ICT and Future Planning, and Deputy Minister of related ministries, the Head of the KCDC, the Director of the MFDS, and the private experts participate.

 

The Pan-Government Working Group analyzes the situation throughout the entire cycle and identifies issues in the field, including COVID-19 treatments, vaccines, R&D, production, national stockpiling, and use of quarantine sites, and prepare a support plan.

 

The Working Group is co-chaired by the Director of the Korea National Institute of Health & Head of R & D Policy of the Science, ICT and Future Planning.

 

In addition, a general subdivision consisting of each division head and the heads of related ministries is operated.

 

The Working Group will hold the first meeting at 8 am today (17th) at the Korea Press Center (Maehwa Hall) as the co-host of the Director of the Korea National Institute of Health and Head of R&D Policy of the Science, ICT and Future Planning.

 

The current status of domestic and foreign COVID-19 treatment, vaccine research and development, and the supply and demand of quarantine products and devices will be reviewed, and the role of the working group to quickly discuss ways to resolve difficulties in the field and plans to support related ministries will be discussed.

 

In particular, the government will prepare a roadmap for the development of COVID-19 treatments and vaccines that contains the government's R&D investment in promising items for COVID-19 treatments and vaccines in Korea, supporting periodic R&D from basic research to commercialization, and plans to improve regulations on licensing and commercialization.

 

According to the Ministry of Health and Welfare, it is planning to discover detailed agendas through regular and intensive discussions on a weekly basis by three divisions (therapeutics, vaccines, quarantine products and devices) under the Working Group.

 

In addition, it is planning to provide professional consulting to quickly resolve the difficulties of domestic therapeutic and vaccine development companies in connection with the 'Company Grievance Relief Support Center (the Korea Health Industry Development Institute)' to be installed under the government support group.

 

In addition, the Ministry of Health and Welfare explained that it will cooperate with each other in the search for solutions to scientific and technological difficulties through the “research and development support council” consisting of government-funded research institutes, universities, and so on.

 

The Joint Promotion Director said that in order to completely overcome Corona 19, early development of therapeutic drugs and vaccines, and proper distribution of quarantine products and devices are essential.

 

He also said that the Working Group would support the pan-government support group and play an active role in identifying and implementing practical improvement measures and solutions based on major issues.